aluates Reports

$ 0.0

Automative

Global Biopharmaceutical CMO and CRO Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-36L1348

Global Biopharmaceutical CMO CRO Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Biopharmaceutical CMO and CRO Market Research Report 2025

Code: QYRE-Auto-36L1348

Report

June 2025

Pages:72

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Lonza

ProBioGen

Samsung Biologics

AGC Biologics

Boehringer Ingelheim International GmbH

FUJIFILM Diosynth Biotechnologies

Inno Bio Ventures Sdn Bhd

JRS Pharma

PRA Health Sciences, Inc.

Rentschler Biopharma SE

Biopharmaceutical CMO and CRO Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Biopharmaceutical CMO and CRO Market

The global market for Biopharmaceutical CMO and CRO was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical CMO and CRO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical CMO and CRO.

The Biopharmaceutical CMO and CRO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biopharmaceutical CMO and CRO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biopharmaceutical CMO and CRO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Biopharmaceutical CMO and CRO Market Report

Report Metric	Details
Report Name	Biopharmaceutical CMO and CRO Market
CAGR	5%
Segment by Type	Contract Manufacturing Contract Research
Segment by Application	Biologics Manuefacturing Biosimilars Manuefacturing Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AGC Biologics, Boehringer Ingelheim International GmbH, FUJIFILM Diosynth Biotechnologies, Inno Bio Ventures Sdn Bhd, JRS PHARMA, Lonza, PRA Health Sciences, Inc., ProBioGen AG, Rentschler Biopharma SE, Samsung BioLogics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharmaceutical CMO and CRO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Biopharmaceutical CMO and CRO Market report?

Ans: The main players in the Biopharmaceutical CMO and CRO Market are AGC Biologics, Boehringer Ingelheim International GmbH, FUJIFILM Diosynth Biotechnologies, Inno Bio Ventures Sdn Bhd, JRS PHARMA, Lonza, PRA Health Sciences, Inc., ProBioGen AG, Rentschler Biopharma SE, Samsung BioLogics

What are the Application segmentation covered in the Biopharmaceutical CMO and CRO Market report?

Ans: The Applications covered in the Biopharmaceutical CMO and CRO Market report are Biologics Manuefacturing, Biosimilars Manuefacturing, Other

What are the Type segmentation covered in the Biopharmaceutical CMO and CRO Market report?

Ans: The Types covered in the Biopharmaceutical CMO and CRO Market report are Contract Manufacturing, Contract Research

Recommended Reports

Biopharma Manufacturing

Cancer & Therapeutics

Biopharma Tools & Accessories

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biopharmaceutical CMO and CRO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Contract Manufacturing

1.2.3 Contract Research

1.3 Market by Application

1.3.1 Global Biopharmaceutical CMO and CRO Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Biologics Manuefacturing

1.3.3 Biosimilars Manuefacturing

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Biopharmaceutical CMO and CRO Market Perspective (2020-2031)

2.2 Global Biopharmaceutical CMO and CRO Growth Trends by Region

2.2.1 Global Biopharmaceutical CMO and CRO Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Biopharmaceutical CMO and CRO Historic Market Size by Region (2020-2025)

2.2.3 Biopharmaceutical CMO and CRO Forecasted Market Size by Region (2026-2031)

2.3 Biopharmaceutical CMO and CRO Market Dynamics

2.3.1 Biopharmaceutical CMO and CRO Industry Trends

2.3.2 Biopharmaceutical CMO and CRO Market Drivers

2.3.3 Biopharmaceutical CMO and CRO Market Challenges

2.3.4 Biopharmaceutical CMO and CRO Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Biopharmaceutical CMO and CRO Players by Revenue

3.1.1 Global Top Biopharmaceutical CMO and CRO Players by Revenue (2020-2025)

3.1.2 Global Biopharmaceutical CMO and CRO Revenue Market Share by Players (2020-2025)

3.2 Global Biopharmaceutical CMO and CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Biopharmaceutical CMO and CRO Revenue

3.4 Global Biopharmaceutical CMO and CRO Market Concentration Ratio

3.4.1 Global Biopharmaceutical CMO and CRO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical CMO and CRO Revenue in 2024

3.5 Global Key Players of Biopharmaceutical CMO and CRO Head office and Area Served

3.6 Global Key Players of Biopharmaceutical CMO and CRO, Product and Application

3.7 Global Key Players of Biopharmaceutical CMO and CRO, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Biopharmaceutical CMO and CRO Breakdown Data by Type

4.1 Global Biopharmaceutical CMO and CRO Historic Market Size by Type (2020-2025)

4.2 Global Biopharmaceutical CMO and CRO Forecasted Market Size by Type (2026-2031)

5 Biopharmaceutical CMO and CRO Breakdown Data by Application

5.1 Global Biopharmaceutical CMO and CRO Historic Market Size by Application (2020-2025)

5.2 Global Biopharmaceutical CMO and CRO Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Biopharmaceutical CMO and CRO Market Size (2020-2031)

6.2 North America Biopharmaceutical CMO and CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Biopharmaceutical CMO and CRO Market Size by Country (2020-2025)

6.4 North America Biopharmaceutical CMO and CRO Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Biopharmaceutical CMO and CRO Market Size (2020-2031)

7.2 Europe Biopharmaceutical CMO and CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Biopharmaceutical CMO and CRO Market Size by Country (2020-2025)

7.4 Europe Biopharmaceutical CMO and CRO Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Biopharmaceutical CMO and CRO Market Size (2020-2031)

8.2 Asia-Pacific Biopharmaceutical CMO and CRO Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Region (2020-2025)

8.4 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Biopharmaceutical CMO and CRO Market Size (2020-2031)

9.2 Latin America Biopharmaceutical CMO and CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Biopharmaceutical CMO and CRO Market Size by Country (2020-2025)

9.4 Latin America Biopharmaceutical CMO and CRO Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Biopharmaceutical CMO and CRO Market Size (2020-2031)

10.2 Middle East & Africa Biopharmaceutical CMO and CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Country (2020-2025)

10.4 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AGC Biologics

11.1.1 AGC Biologics Company Details

11.1.2 AGC Biologics Business Overview

11.1.3 AGC Biologics Biopharmaceutical CMO and CRO Introduction

11.1.4 AGC Biologics Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)

11.1.5 AGC Biologics Recent Development

11.2 Boehringer Ingelheim International GmbH

11.2.1 Boehringer Ingelheim International GmbH Company Details

11.2.2 Boehringer Ingelheim International GmbH Business Overview

11.2.3 Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Introduction

11.2.4 Boehringer Ingelheim International GmbH Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)

11.2.5 Boehringer Ingelheim International GmbH Recent Development

11.3 FUJIFILM Diosynth Biotechnologies

11.3.1 FUJIFILM Diosynth Biotechnologies Company Details

11.3.2 FUJIFILM Diosynth Biotechnologies Business Overview

11.3.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Introduction

11.3.4 FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)

11.3.5 FUJIFILM Diosynth Biotechnologies Recent Development

11.4 Inno Bio Ventures Sdn Bhd

11.4.1 Inno Bio Ventures Sdn Bhd Company Details

11.4.2 Inno Bio Ventures Sdn Bhd Business Overview

11.4.3 Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Introduction

11.4.4 Inno Bio Ventures Sdn Bhd Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)

11.4.5 Inno Bio Ventures Sdn Bhd Recent Development

11.5 JRS PHARMA

11.5.1 JRS PHARMA Company Details

11.5.2 JRS PHARMA Business Overview

11.5.3 JRS PHARMA Biopharmaceutical CMO and CRO Introduction

11.5.4 JRS PHARMA Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)

11.5.5 JRS PHARMA Recent Development

11.6 Lonza

11.6.1 Lonza Company Details

11.6.2 Lonza Business Overview

11.6.3 Lonza Biopharmaceutical CMO and CRO Introduction

11.6.4 Lonza Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)

11.6.5 Lonza Recent Development

11.7 PRA Health Sciences, Inc.

11.7.1 PRA Health Sciences, Inc. Company Details

11.7.2 PRA Health Sciences, Inc. Business Overview

11.7.3 PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Introduction

11.7.4 PRA Health Sciences, Inc. Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)

11.7.5 PRA Health Sciences, Inc. Recent Development

11.8 ProBioGen AG

11.8.1 ProBioGen AG Company Details

11.8.2 ProBioGen AG Business Overview

11.8.3 ProBioGen AG Biopharmaceutical CMO and CRO Introduction

11.8.4 ProBioGen AG Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)

11.8.5 ProBioGen AG Recent Development

11.9 Rentschler Biopharma SE

11.9.1 Rentschler Biopharma SE Company Details

11.9.2 Rentschler Biopharma SE Business Overview

11.9.3 Rentschler Biopharma SE Biopharmaceutical CMO and CRO Introduction

11.9.4 Rentschler Biopharma SE Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)

11.9.5 Rentschler Biopharma SE Recent Development

11.10 Samsung BioLogics

11.10.1 Samsung BioLogics Company Details

11.10.2 Samsung BioLogics Business Overview

11.10.3 Samsung BioLogics Biopharmaceutical CMO and CRO Introduction

11.10.4 Samsung BioLogics Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)

11.10.5 Samsung BioLogics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Lonza

ProBioGen

Samsung Biologics

AGC Biologics

Boehringer Ingelheim International GmbH

FUJIFILM Diosynth Biotechnologies

Inno Bio Ventures Sdn Bhd

JRS Pharma

PRA Health Sciences, Inc.

Rentschler Biopharma SE

List of Tables

Table 1. Global Biopharmaceutical CMO and CRO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Contract Manufacturing

Table 3. Key Players of Contract Research

Table 4. Global Biopharmaceutical CMO and CRO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Biopharmaceutical CMO and CRO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Biopharmaceutical CMO and CRO Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Biopharmaceutical CMO and CRO Market Share by Region (2020-2025)

Table 8. Global Biopharmaceutical CMO and CRO Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Biopharmaceutical CMO and CRO Market Share by Region (2026-2031)

Table 10. Biopharmaceutical CMO and CRO Market Trends

Table 11. Biopharmaceutical CMO and CRO Market Drivers

Table 12. Biopharmaceutical CMO and CRO Market Challenges

Table 13. Biopharmaceutical CMO and CRO Market Restraints

Table 14. Global Biopharmaceutical CMO and CRO Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Biopharmaceutical CMO and CRO Market Share by Players (2020-2025)

Table 16. Global Top Biopharmaceutical CMO and CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO and CRO as of 2024)

Table 17. Ranking of Global Top Biopharmaceutical CMO and CRO Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Biopharmaceutical CMO and CRO Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Biopharmaceutical CMO and CRO, Headquarters and Area Served

Table 20. Global Key Players of Biopharmaceutical CMO and CRO, Product and Application

Table 21. Global Key Players of Biopharmaceutical CMO and CRO, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Biopharmaceutical CMO and CRO Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Biopharmaceutical CMO and CRO Revenue Market Share by Type (2020-2025)

Table 25. Global Biopharmaceutical CMO and CRO Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Biopharmaceutical CMO and CRO Revenue Market Share by Type (2026-2031)

Table 27. Global Biopharmaceutical CMO and CRO Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Biopharmaceutical CMO and CRO Revenue Market Share by Application (2020-2025)

Table 29. Global Biopharmaceutical CMO and CRO Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Biopharmaceutical CMO and CRO Revenue Market Share by Application (2026-2031)

Table 31. North America Biopharmaceutical CMO and CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Biopharmaceutical CMO and CRO Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Biopharmaceutical CMO and CRO Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Biopharmaceutical CMO and CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Biopharmaceutical CMO and CRO Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Biopharmaceutical CMO and CRO Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Biopharmaceutical CMO and CRO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Biopharmaceutical CMO and CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Biopharmaceutical CMO and CRO Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Biopharmaceutical CMO and CRO Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Biopharmaceutical CMO and CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Country (2026-2031) & (US$ Million)

Table 46. AGC Biologics Company Details

Table 47. AGC Biologics Business Overview

Table 48. AGC Biologics Biopharmaceutical CMO and CRO Product

Table 49. AGC Biologics Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)

Table 50. AGC Biologics Recent Development

Table 51. Boehringer Ingelheim International GmbH Company Details

Table 52. Boehringer Ingelheim International GmbH Business Overview

Table 53. Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Product

Table 54. Boehringer Ingelheim International GmbH Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)

Table 55. Boehringer Ingelheim International GmbH Recent Development

Table 56. FUJIFILM Diosynth Biotechnologies Company Details

Table 57. FUJIFILM Diosynth Biotechnologies Business Overview

Table 58. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Product

Table 59. FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)

Table 60. FUJIFILM Diosynth Biotechnologies Recent Development

Table 61. Inno Bio Ventures Sdn Bhd Company Details

Table 62. Inno Bio Ventures Sdn Bhd Business Overview

Table 63. Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Product

Table 64. Inno Bio Ventures Sdn Bhd Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)

Table 65. Inno Bio Ventures Sdn Bhd Recent Development

Table 66. JRS PHARMA Company Details

Table 67. JRS PHARMA Business Overview

Table 68. JRS PHARMA Biopharmaceutical CMO and CRO Product

Table 69. JRS PHARMA Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)

Table 70. JRS PHARMA Recent Development

Table 71. Lonza Company Details

Table 72. Lonza Business Overview

Table 73. Lonza Biopharmaceutical CMO and CRO Product

Table 74. Lonza Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)

Table 75. Lonza Recent Development

Table 76. PRA Health Sciences, Inc. Company Details

Table 77. PRA Health Sciences, Inc. Business Overview

Table 78. PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Product

Table 79. PRA Health Sciences, Inc. Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)

Table 80. PRA Health Sciences, Inc. Recent Development

Table 81. ProBioGen AG Company Details

Table 82. ProBioGen AG Business Overview

Table 83. ProBioGen AG Biopharmaceutical CMO and CRO Product

Table 84. ProBioGen AG Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)

Table 85. ProBioGen AG Recent Development

Table 86. Rentschler Biopharma SE Company Details

Table 87. Rentschler Biopharma SE Business Overview

Table 88. Rentschler Biopharma SE Biopharmaceutical CMO and CRO Product

Table 89. Rentschler Biopharma SE Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)

Table 90. Rentschler Biopharma SE Recent Development

Table 91. Samsung BioLogics Company Details

Table 92. Samsung BioLogics Business Overview

Table 93. Samsung BioLogics Biopharmaceutical CMO and CRO Product

Table 94. Samsung BioLogics Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)

Table 95. Samsung BioLogics Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Biopharmaceutical CMO and CRO Picture

Figure 2. Global Biopharmaceutical CMO and CRO Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Biopharmaceutical CMO and CRO Market Share by Type: 2024 VS 2031

Figure 4. Contract Manufacturing Features

Figure 5. Contract Research Features

Figure 6. Global Biopharmaceutical CMO and CRO Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Biopharmaceutical CMO and CRO Market Share by Application: 2024 VS 2031

Figure 8. Biologics Manuefacturing Case Studies

Figure 9. Biosimilars Manuefacturing Case Studies

Figure 10. Other Case Studies

Figure 11. Biopharmaceutical CMO and CRO Report Years Considered

Figure 12. Global Biopharmaceutical CMO and CRO Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Biopharmaceutical CMO and CRO Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Biopharmaceutical CMO and CRO Market Share by Region: 2024 VS 2031

Figure 15. Global Biopharmaceutical CMO and CRO Market Share by Players in 2024

Figure 16. Global Top Biopharmaceutical CMO and CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO and CRO as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Biopharmaceutical CMO and CRO Revenue in 2024

Figure 18. North America Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Biopharmaceutical CMO and CRO Market Share by Country (2020-2031)

Figure 20. United States Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Biopharmaceutical CMO and CRO Market Share by Country (2020-2031)

Figure 24. Germany Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Biopharmaceutical CMO and CRO Market Share by Region (2020-2031)

Figure 32. China Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Biopharmaceutical CMO and CRO Market Share by Country (2020-2031)

Figure 40. Mexico Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Biopharmaceutical CMO and CRO Market Share by Country (2020-2031)

Figure 44. Turkey Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. AGC Biologics Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)

Figure 48. Boehringer Ingelheim International GmbH Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)

Figure 49. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)

Figure 50. Inno Bio Ventures Sdn Bhd Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)

Figure 51. JRS PHARMA Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)

Figure 52. Lonza Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)

Figure 53. PRA Health Sciences, Inc. Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)

Figure 54. ProBioGen AG Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)

Figure 55. Rentschler Biopharma SE Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)

Figure 56. Samsung BioLogics Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Drug Discovery CRO Market Research Report 2025

Drug Preclinical CRO Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmaceutical CRDMO Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cell Therapy CMO Market Research Report 2025

Marine Biopharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Contract Research Organization CRO and CDMO for Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biopharmaceuticals Excipients Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biopharma Cosmetics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biopharmaceutical Excipient Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biopharmaceutical Packaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Automation in Biopharma Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Bulk Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biopharma Contract Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmaceuticals and Biotechnology R D Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmaceutical Grade Cholesterol Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biopharmaceuticals Contract Manufacturing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions